AINDEX
Markets

Veraxa Biotech AG (VRXA)

VRXANASDAQ-GMBiotechnology: Pharmaceutical Preparations

$1.04

-0.0050 (-0.48%) today

At the close, Nov 17, 4:00 PM ET. After hours $1.02 -1.83%

-0.48% 1D
Market cap
$147.06m
P/E
–
EPS, last 4 quarters
–
Dividend yield
–
Day range
$1.03 to $1.06
52-week range
$0.9000 to $27.36
Average volume
–
Previous close
$1.05

News

7 latest

The company

At VERAXA, we are building a premier engine for the discovery and development of next-generation antibody-based therapeutics, including bispecific T cell engagers, bispecific ADCs and other innovative formats. Powered by a suite of transformative technologies and guided by rigorous quality-by-design principles, we are rapidly advancing our pipeline of ADCs and proprietary BiTAC formats into clinical development and beyond. VERAXA was founded on scientific breakthroughs made at the European Molecular Biology Laboratory (EMBL), a world-renowned institution known for pioneering life science research and cutting-edge technology.

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Exchange
NASDAQ-GM
Region
Europe
Website
veraxa.com

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.